Diabetes Mellitus: all 11,090 studies

Page 33 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesCompletedNCT00469092Phase 4Results posted
• A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 DiabetesCompletedNCT00467649Phase 4Results posted
• Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVECompletedNCT00461630Phase 3Results posted
• Comparison of Insulins Aspart and Lispro in Insulin PumpsCompletedNCT00461331Phase 4Results posted
• Role of Exenatide in Type 1 DiabetesCompletedNCT00456300Phase 2Results posted
• Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in KoreaCompletedNCT00455858Phase 4Results posted
• TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)TerminatedNCT00451321Phase 2Results posted
• Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)CompletedNCT00449930Phase 3Results posted
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedNCT00447382Phase 3Results posted
• Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes MellitusCompletedNCT00442767Phase 4Results posted
• A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.TerminatedNCT00437489Phase 4Results posted
• Islet Transplantation for Type 1 Diabetes MellitusTerminatedNCT00437398Phase 1/2Results posted
• Vitamin D and Calcium Homeostasis for Prevention of Type 2 DiabetesCompletedNCT00436475Phase 1/2Results posted
• Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedNCT00435019Phase 3Results posted
• Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 DiabetesCompletedNCT00434954Phase 3Results posted
• Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 DiabetesCompletedNCT00432809Not applicableResults posted
• A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo StudyCompletedNCT00432679Phase 3Results posted
• Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00432276Phase 3Results posted
• Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.TerminatedNCT00430040Phase 4Results posted
• Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial TriglycerideCompletedNCT00424762Phase 4Results posted
• Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)CompletedNCT00423488Phase 3Results posted
• A Study for Patients With Diabetes Mellitus (IOPA)CompletedNCT00420095Phase 4Results posted
• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes MellitusCompletedNCT00419562Phase 3Results posted
• Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in YouthCompletedNCT00413335Not applicableResults posted
• A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)CompletedNCT00411554Phase 3Results posted
• Multi-Targeted Cardiac Risk Intervention in Type 2 DiabetesCompletedNCT00409240Phase 3Results posted
• Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 DiabetesCompletedNCT00406133Phase 3Results posted
• Initial Combination With Pioglitazone Study (0431-064)CompletedNCT00397631Phase 3Results posted
• Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00395746Phase 3Results posted
• Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCompletedNCT00395512Phase 3Results posted
• Sitagliptin Added-on to Insulin Study (0431-051)CompletedNCT00395343Phase 3Results posted
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00393718Phase 3Results posted
• Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)CompletedNCT00392678Phase 2/3Results posted
• A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminCompletedNCT00386100Phase 4Results posted
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes MellitusCompletedNCT00385697Phase 2/3Results posted
• Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes OutcomesCompletedNCT00383110Results posted
• RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesCompletedNCT00379769Phase 3Results posted
• Anti-CD3 mAb Treatment of Recent Onset Type 1 DiabetesCompletedNCT00378508Phase 2Results posted
• Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)CompletedNCT00377858Phase 4Results posted
• Safety and Tolerability Study of Cycloset in Treatment of Type 2 DiabetesCompletedNCT00377676Phase 3Results posted
• Study Of GW823093 In Japanese Subjects With Type 2 Diabetes MellitusCompletedNCT00372957Phase 2Results posted
• MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)CompletedNCT00372060Phase 3Results posted
• The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 DiabetesTerminatedNCT00366301Phase 4Results posted
• A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes PatientsCompletedNCT00360334Phase 3Results posted
• Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular SafetyCompletedNCT00359801Phase 4Results posted
• Exenatide Versus Glimepiride in Patients With Type 2 DiabetesCompletedNCT00359762Phase 3Results posted
• Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)CompletedNCT00357890Not applicableResults posted
• A Pilot Study of BMS-512148 in Subjects With Type 2 DiabetesCompletedNCT00357370Phase 2/3Results posted
• A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®TerminatedNCT00356421Phase 4Results posted
• The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 DiabetesCompletedNCT00353834Phase 4Results posted
• Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes MellitusCompletedNCT00351000Phase 4Results posted
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)CompletedNCT00350779Phase 3Results posted
• Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 DiabetesCompletedNCT00348374Phase 3Results posted
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaCompletedNCT00344370Phase 3Results posted
• The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy VolunteersCompletedNCT00339833Phase 4Results posted
• Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes MellitusCompletedNCT00337610Phase 3Results posted
• Telerehabilitation Intervention to Promote Exercise for DiabetesCompletedNCT00334113Not applicableResults posted
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 DiabetesCompletedNCT00332488Phase 3Results posted
• Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00328627Phase 3Results posted
• Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes PatientsCompletedNCT00328172Phase 2Results posted
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00327015Phase 3Results posted
• Intensive Glycemic Control and Skeletal Health StudyCompletedNCT00324350Phase 3Results posted
• The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 DiabetesCompletedNCT00321321Phase 2Results posted
• Microalbuminuria in Children With and Without DiabetesCompletedNCT00320086Results posted
• To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherCompletedNCT00318461Phase 3Results posted
• Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseCompletedNCT00316082Phase 3Results posted
• Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 DiabetesCompletedNCT00315939Not applicableResults posted
• Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes MellitusTerminatedNCT00315614Phase 2Results posted
• Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney TransplantationCompletedNCT00315588Phase 2Results posted
• A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasCompletedNCT00313313Phase 3Results posted
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaCompletedNCT00309751Phase 3Results posted
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 DiabetesCompletedNCT00309608Phase 2Results posted
• Perioperative Insulin Glargine Dosing StudyCompletedNCT00309465Phase 4Results posted
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-upCompletedNCT00309244Phase 3Results posted
• Safety of Inhaled Insulin With Type 1 and Type 2 DiabetesCompletedNCT00308737Phase 3Results posted
• Efficacy & Safety of Inhaled Insulin in Type 1 DiabetesCompletedNCT00308308Phase 3Results posted
• Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)CompletedNCT00308139Phase 3Results posted
• Long-term Safety of Alogliptin in Patients With Type 2 Diabetes MellitusCompletedNCT00306384Phase 3Results posted
• Umbilical Cord Blood Infusion to Treat Type 1 DiabetesCompletedNCT00305344Phase 1/2Results posted
• Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal DiseaseCompletedNCT00296374Phase 2Results posted
• Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)CompletedNCT00296296Phase 4Results posted
• To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cTerminatedNCT00294723Phase 3Results posted
• MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)CompletedNCT00289848Phase 3Results posted
• Can Group Visits Improve Outcomes of Veterans With DiabetesCompletedNCT00286741Phase 3Results posted
• Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00286494Phase 3Results posted
• Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.CompletedNCT00286468Phase 3Results posted
• Efficacy and Safety of Alogliptin in Subjects With Type 2 DiabetesCompletedNCT00286455Phase 3Results posted
• Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes MellitusCompletedNCT00286442Phase 3Results posted
• Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.CompletedNCT00286429Phase 3Results posted
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlTerminatedNCT00283049Phase 4Results posted
• A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes MellitusTerminatedNCT00282971Phase 3Results posted
• Rituximab in New Onset Type 1 DiabetesCompletedNCT00279305Phase 2Results posted
• The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)CompletedNCT00279201Phase 4Results posted
• Randomized Trial of Telemedicine for Diabetes CareCompletedNCT00271739Not applicableResults posted
• Improving Diabetes Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource NurseCompletedNCT00258674Not applicableResults posted
• A Study In Patients With Type 2 Diabetes MellitusCompletedNCT00256867Phase 3Results posted
• Empowering Patients to Better Manage Diabetes Through Self-CareCompletedNCT00254501Phase 3Results posted
• A Study Comparing Standard Care for Diabetes to Case-managed Care for Diabetes in Patients With Coronary Artery DiseaseCompletedNCT00248352Not applicableResults posted
• Preservation of Beta-cell Function in Type 2 Diabetes MellitusCompletedNCT00232583Not applicableResults posted
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesCompletedNCT00229658Results posted

← Diabetes Mellitus overview